» Articles » PMID: 21840486

A Cullin3-KLHL20 Ubiquitin Ligase-dependent Pathway Targets PML to Potentiate HIF-1 Signaling and Prostate Cancer Progression

Abstract

Tumor hypoxia is associated with disease progression and treatment failure, but the hypoxia signaling mechanism is not fully understood. Here, we show that KLHL20, a Cullin3 (Cul3) substrate adaptor induced by HIF-1, coordinates with the actions of CDK1/2 and Pin1 to mediate hypoxia-induced PML proteasomal degradation. Furthermore, this PML destruction pathway participates in a feedback mechanism to maximize HIF-1α induction, thereby potentiating multiple tumor hypoxia responses, including metabolic reprogramming, epithelial-mesenchymal transition, migration, tumor growth, angiogenesis, and chemoresistance. In human prostate cancer, overexpression of HIF-1α, KLHL20, and Pin1 correlates with PML down-regulation, and hyperactivation of the PML destruction pathway is associated with disease progression. Our study indicates that the KLHL20-mediated PML degradation and HIF-1α autoregulation play key roles in tumor progression.

Citing Articles

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P Cancers (Basel). 2025; 17(5).

PMID: 40075679 PMC: 11899103. DOI: 10.3390/cancers17050832.


A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins.

Ganesan I, Kiyokawa H Cancers (Basel). 2025; 17(4).

PMID: 40002221 PMC: 11853300. DOI: 10.3390/cancers17040626.


Temporal and Spatial Characterization of CUL3-driven Targeted Degradation of BET family, BRD Proteins by the Macrocycle-based Degrader BTR2004.

Fechtmeyer P, Yeh J bioRxiv. 2024; .

PMID: 39677683 PMC: 11643031. DOI: 10.1101/2024.12.07.627262.


Pin1 promotes human Ca2.1 channel polyubiquitination by RNF138: pathophysiological implication for episodic ataxia type 2.

Fu S, Cheng K, Hsiao C, Fang Y, Jeng C, Tang C Cell Commun Signal. 2024; 22(1):571.

PMID: 39609819 PMC: 11603662. DOI: 10.1186/s12964-024-01960-9.


A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway.

Pauzaite T, Nathan J Biochem Soc Trans. 2024; 52(6):2253-2265.

PMID: 39584532 PMC: 11668284. DOI: 10.1042/BST20230861.